This Is Not a TestThe FDA’s RMAT designation goes live
Tue, 04/11/2017 - 12:00
(FDA: Silver Spring, MD) -- The field of regenerative medicine encompasses a wide scope of innovative products including cell therapies, therapeutic tissue engineering products, human cell and tissue products, and certain combination products using… The Center for Biologics Evaluation Keeps Biological Product Standards HighA laboratory quality management system is key
Thu, 03/03/2016 - 12:26
Part of the vision of the Center for Biologics Evaluation and Research (CBER) is to strengthen the center as the preeminent regulatory organization for biologics. One way CBER is achieving this is through the work of the Office of Compliance and…
